ZhihuiAmy Liu

发表

A. Bezjak, N. Adhikari, L. Dawson, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab

D. Cescon, T. Mak, H. Berman, 2022, Journal for ImmunoTherapy of Cancer.

Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study

L. Dawson, D. Hedley, P. Lindsay, 2022, Diseases of the colon and rectum.

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer

C. Ménard, R. Weersink, A. Berlin, 2022, Frontiers in Oncology.

Prognostic value of PET/CT and MR-based baseline radiomics among patients with Nasopharyngeal Carcinoma

A. Kohan, R. Hinzpeter, ZhihuiAmy Liu, 2022 .

Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset

W. Foulkes, A. Shlien, R. McWilliams, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A risk stratification model for toxicities in phase 1 immunotherapy trials.

L. Siu, A. Salawu, M. Oliva, 2022, European journal of cancer.

Jih-Hsiang Lee, H. Takami, Y. Narita, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Neurocognitive Performance in Adults Treated With Radiation for a Primary Brain Tumor

W. Mason, L. Bernstein, N. Richard, 2022, Advances in radiation oncology.

Evaluating the Short-term Environmental and Clinical Effects of a Radiation Oncology Department's Response to the COVID-19 Pandemic

Fei Liu, H. Keller, P. Wong, 2022, International Journal of Radiation Oncology*Biology*Physics.

Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma

B. O'Sullivan, P. Veit-Haibach, U. Metser, 2022, Frontiers in Oncology.

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

Trevor J Pugh, K. Cole, T. Pugh, 2022, Nature Medicine.

Photon versus proton whole ventricular radiotherapy for non‐germinomatous germ cell tumors: A report from the Children's Oncology Group

G. Dhall, D. Tsang, S. MacDonald, 2022, Pediatric blood & cancer.

Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience

A. Berlin, A. Prica, T. Truong, 2023, JCO oncology practice.

Prognostic Value of Sarcopenia and Metabolic Parameters of 18F-FDG-PET/CT in Patients with Advanced Gastroesophageal Cancer

P. Veit-Haibach, R. Jang, U. Metser, 2023, Diagnostics.

Evaluating Healthcare Professionals' Knowledge, Attitudes, Practices and Education Interest in LGBTQ2 + Cancer Care.

G. Shapiro, J. Weiss, J. Croke, 2022, Journal of cancer education : the official journal of the American Association for Cancer Education.

Feasibility of implementing a cervix cancer–specific patient-reported outcome measure in routine ambulatory clinics

L. Barbera, J. Croke, D. Howell, 2020, Supportive Care in Cancer.

Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey

E. Zubizarreta, Y. Lievens, M. Yap, 2023, JCO global oncology.

Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE

L. Minasian, Philippe Bédard, L. Siu, 2022, British Journal of Cancer.

Combined 18F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer

P. Veit-Haibach, G. Darling, R. Jang, 2022, Clinical nuclear medicine.

Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer

P. Veit-Haibach, R. Jang, U. Metser, 2022, Cancers.

Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy.

R. Weersink, A. Fyles, A. Beiki-Ardakani, 2022, Brachytherapy.

Estimating Potential Benefits to Neurocognition with Proton Therapy in Adults with Brain Tumors

D. Tsang, A. Parent, G. Tsui, 2023, International journal of particle therapy.

Dosimetric evaluation of adult and paediatric brain tumours planned using mask‐based cobalt‐60 fractionated stereotactic radiotherapy compared to linear accelerator‐based volumetric modulated arc therapy

Young-Bin Cho, D. Tsang, D. Shultz, 2022, Journal of medical radiation sciences.

A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events

L. Minasian, Philippe Bédard, L. Siu, 2023, British Journal of Cancer.

Disparity and Diversity in NSCLC Imaging and Genomics: Evaluation of a Mature, Multicenter Database

P. Veit-Haibach, U. Metser, C. Ortega, 2023, Cancers.

Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up

P. Veit-Haibach, A. Hope, Xuan Li, 2022, Cancers.

Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis

M. Butler, N. Laperriere, P. Kongkham, 2023, Journal of Neuro-Oncology.

Virtual Care and Electronic Patient Communication During COVID-19: Cross-sectional Study of Inequities Across a Canadian Tertiary Cancer Center

A. Berlin, T. Truong, N. Abdelmutti, 2022, Journal of medical Internet research.

Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer

C. Catton, A. Zlotta, A. Berlin, 2023, Radiation Oncology.

Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy.

R. Weersink, A. Fyles, A. Beiki-Ardakani, 2022, Brachytherapy.